SR 57227A hydrochloride - CAS 77145-61-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C10H14ClN3.HCl
Molecular Weight:
248.15
COA:
Inquire
Targets:
5-HT Receptor
Description:
SR 57227 hydrochloride is a selective and high affinity 5-HT3 receptor agonist. SR 57227 exhibits anti-depressant like effects and decreases isolation-induced aggressive behavior in rat model.
Brife Description:
5-HT3 receptor agonist
Purity:
≥99% by HPLC
Appearance:
Off-White to Pale Orange Solid
Synonyms:
SR 57227A hydrochloride; SR57227A hydrochloride; SR-57227A hydrochloride; 1-(6-Chloro-2-pyridinyl)-4-piperidinamine hydrochloride; 4-amino-1-(6-chloro-2-pyridyl)-piperidine hydrochloride
MSDS:
Inquire
InChIKey:
FUMINTAAUJUVMP-UHFFFAOYSA-N
InChI:
InChI=1S/C10H14ClN3.ClH/c11-9-2-1-3-10(13-9)14-6-4-8(12)5-7-14;/h1-3,8H,4-7,12H2;1H
Canonical SMILES:
C1CN(CCC1N)C2=NC(=CC=C2)Cl.Cl
1.Bidirectional allosteric modulation of strychnine-sensitive glycine receptors by tropeines and 5-HT3 serotonin receptor ligands.
Maksay G Neuropharmacology. 1998 Dec;37(12):1633-41.
Specific binding of [3H]strychnine was studied on membranes prepared from rat spinal cord. Several antagonists and agonists of 5-HT3 receptors and tropane derivatives displaced [3H]strychnine binding with micromolar potencies. In the presence of 10 microM glycine a high affinity (nanomolar) component of displacement was also observed for the tropeines zatosetron, bemesetron and tropisetron. The displacing potency of glycine was also enhanced by these agents which are therefore termed glycine-positive. In contrast, atropine, SR 57227A, m-chlorophenylbiguanide, metoclopramide and granisetron are termed glycine-negative, because they decreased the displacing potency of glycine while glycine decreased the displacing potencies of atropine and metoclopramide. The dissociation of [3H]strychnine binding was accelerated in the presence of m-chlorophenylbiguanide, SR 57227A, atropine and zatosetron with a concentration dependence (EC50 values and Hill slopes) similar to their displacing effects. This demonstrates that the displacement of strychnine binding is associated with allosteric interactions between different binding sites. Structure-activity analysis revealed that the tropeine structure is essential for high affinity binding, and its substitutions (in scopolamine and cocaine) or its replacement (in ondansetron and metoclopramide) strongly decrease the potency and/or efficacy of allosteric modulation.
2.Contribution of Hippocampal 5-HT
Wu ZM;Yang LH;Cui R;Ni GL;Wu FT;Liang Y Cell Mol Neurobiol. 2017 May;37(4):595-606. doi: 10.1007/s10571-016-0395-7. Epub 2016 Jun 21.
One of the hypotheses about the pathogenesis of posttraumatic stress disorder (PTSD) is the dysfunction of serotonin (5-HT) neurotransmission. While certain 5-HT receptor subtypes are likely critical for the symptoms of PTSD, few studies have examined the role of 5-HT;3; receptor in the development of PTSD, even though 5-HT;3; receptor is critical for contextual fear extinction and anxiety-like behavior. Therefore, we hypothesized that stimulation of 5-HT;3; receptor in the dorsal hippocampus (DH) could prevent hippocampal autophagy and the development of PTSD-like behavior in animals. To this end, we infused SR57227, selective 5-HT;3; agonist, into the DH after a single prolonged stress (SPS) treatment in rats. Three weeks later, we evaluated the effects of this pharmacological treatment on anxiety-related behaviors and extinction of contextual fear memory. We also accessed hippocampal autophagy and the expression of 5-HT;3A; subunit, Beclin-1, LC3-I, and LC3-II in the DH. We found that SPS treatment did not alter anxiety-related behaviors but prolonged the extinction of contextual fear memory, and such a behavioral phenomenon was correlated with increased hippocampal autophagy, decreased 5-HT;3A; expression, and increased expression of Beclin-1 and LC3-II/LC3-I ratio in the DH.
3.Serotonin3 receptor agonists attenuate glutamate-induced firing in rat hippocampal CA1 pyramidal cells.
Zhang JY;Zeise ML;Wang RY Neuropharmacology. 1994 Mar-Apr;33(3-4):483-91.
The techniques of extracellular single cell recording and microiontophoresis were used to study the effect of 5-HT3 receptor agonists on glutamate-activated firing of CA1 hippocampal pyramidal cells. Iontophoretic application of 5-HT3 receptor agonists 2-methyl-5-HT and SR 57227A produced a current (dose)-dependent suppression of the firing of CA1 pyramidal cells; SR 57227A was more effective than 2-methyl-5-HT. The suppressant action of 2-methyl-5-HT and SR 57227A had a slow onset and showed little or no desensitization. This effect was markedly attenuated or completely blocked by the 5-HT3 receptor antagonist BRL 46470A but not by the nonspecific 5-HT1 and 5-HT2 receptor antagonist metergoline or by the 5-HT1A antagonist WAY 100478. Intravenous administration of SR 57227A was effective in reducing the firing rate of CA1 pyramidal cells and this effect was prevented by BRL 46470A administered either i.v. or iontophoretically. Iontophoresis of 2-methyl-5-HT also diminished CA1 postsynaptic field potentials evoked by electrical stimulation of the Schaffer collaterals. Again, BRL 46470A but not metergoline prevented the suppressant action of 2-methyl-5-HT. Taken together, our results indicate that activation of 5-HT3-like receptors in the hippocampal CA1 region effectively reduces the efficacy of glutamatergic neurotransmission.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related 5-HT Receptor Products


CAS 367514-88-3 Lurasidone hydrochloride

Lurasidone hydrochloride
(CAS: 367514-88-3)

Lurasidone is an atypical antipsychotic, inhibits Dopamine D2, 5-HT2A, 5-HT7, 5-HT1A and noradrenaline α2C with IC50 of 1.68 nM, 2.03 nM, 0.495 nM, 6.75 nM and ...

CAS 69906-86-1 Cyanopindolol hemifumarate

Cyanopindolol hemifumarate
(CAS: 69906-86-1)

Cyanopindolol hemifumarate is the hemifumarate salt of cyanopindolol, which is a 5-HT1A/1B antagonist. It is also a β-adrenoceptor antagonist. It has roughly eq...

CAS 175673-57-1 MDL 100009

MDL 100009
(CAS: 175673-57-1)

MDL 100009 is the S-enantiomer of MDL 100151, which is a selective 5-HT2A antagonist.

CAS 149055-79-8 WAY 100135 dihydrochloride

WAY 100135 dihydrochloride
(CAS: 149055-79-8)

WAY 100135 dihydrochloride is a selective 5-HT1A antagonist (IC50 = 15 nM).

CAS 1331782-27-4 PF-04995274

PF-04995274
(CAS: 1331782-27-4)

PF-04995274 is a 5-HT4 receptor partial agonist with Ki = 0.15 - 0.46 nM for 5-HT4 isoforms a, b, d and e, developed for the treatment of Alzheimer's disease (A...

CAS 85650-56-2 Asenapine Maleate

Asenapine Maleate
(CAS: 85650-56-2)

Asenapine Maleate is a 5-HT receptor antagonist used for the treatment of acute schizophrenia and bipolar mania. It is a second-generation (atypical) antipsycho...

CAS 286369-38-8 S 14506 hydrochloride

S 14506 hydrochloride
(CAS: 286369-38-8)

S 14506 hydrochloride is a highly potent and selective 5-HT1A receptor full agonist (pKi = 9.0, 6.6, 7.5, 6.6 and < 6.0 for 5-HT1A, 5-HT1B, 5-HT1C, 5-HT2 and 5-...

CAS 139290-65-6 MDL 100907

MDL 100907
(CAS: 139290-65-6)

MDL 100907 is a selective 5-HT2A receptor antagonist with Ki value of 0.36 nM. It shows antipsychotic activity, attenuates impulsivity, and augments antidepress...

Chemical Structure

CAS 77145-61-0 SR 57227A hydrochloride

Quick Inquiry

Verification code

Featured Items